<?xml version='1.0' encoding='UTF-8'?>
<quiz><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>You are seeing a patient who has been exposed to a medication. You look it up in the register of pregnancy medications. It is listed as category C. The patient asks you what this means. Which of the following is your best response?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57137</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>There are some fetal risks, but benefits may outweigh risks under certain circumstances; thus, patients should be warned.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Animal studies have not shown any fetal risk, or suggested some risk not confirmed in humans, or there are not adequate studies in women.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>The drug has been evaluated in well-controlled human studies and no fetal risk has been shown.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Fetal abnormalities have occurred in animal and human studies, the risk is greater than the benefit, and the drug is contraindicated in pregnancy.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Animal studies have shown adverse effects, but there are no adequately controlled studies in</p>

<p>humans.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 22-year-old woman and her husband are being counseled after a first-trimester miscarriage. She has no significant medical problems. Her physical examination is unremarkable and in counseling her you explain in lay terms that the most likely cause of her miscarriage is aneu-ploidy. Which of the following is the most common aneuploidy causing miscarriage?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57141</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Trisomy 18</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>tetraploidy</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>triploidy(</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>unbalanced translocation</p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>45,XO(</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following is the most common complication of full anticoagulation with low-molecularweight heparin?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57143</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>ulcers</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>renal stones (nephrolithiasis)</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>bleeding</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>thromboembolism</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>osteoporosis</p>

<p> </p>

<p> </p>

<p> </p>

<p>(E) thromboembolism</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A woman with a severe ankle sprain was prescribed ibuprofen for 72 hours. At what gestational age should she avoid this medication?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57146</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>after 36 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>during lactation</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>any gestational age</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>before 12 weeks and after 26 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>after 32 weeks</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>During pregnancy, what is the safest analgesic with the least fetal affect?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57149</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>oxycodone</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>gabapentin</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>acetaminophen</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ibuprofen</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>aspirin</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>The placenta is supplied by two umbilical arteries that carry deoxygenated fetal blood. This blood flows into intervillous capillaries and back to the fetus in the single umbilical vein. The maternal circulation is designed to bathe the placental villi to optimize transport across the placenta of nutrients, oxygen, and metabolic wastes. Which of the following best describes the path of the maternal blood flow?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57151</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>veins to placental capillaries to arteries</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>arteries to placental capillaries to veins</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>arteries to intravillous spaces to veins</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>veins to intravillous spaces to arteries</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>intravillous spaces to arteries to veins</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A chronic hypertensive patient presents with complaints of decreased fetal movement. Her prenatal care has been sporadic but it appears that she is at 37 weeks’ gestation with an estimated fetal weight of 2,200 g. Concerns are raised regarding placental reserves for oxygenating the fetus. This can be most directly assessed by which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57152</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p> a fetal ultrasound growth curve</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>maternal estriol production</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>biophysical profile</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>maternal alpha-fetoprotein</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> lecithin/sphingomyelin (L/S) ratio</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>In the fetus, the most well-oxygenated blood is allowed into the systemic circulation by which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57153</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>ligamentum teres</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>right ventricle</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>foramen ovale</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ligamentum venosum</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ductus arteriosus</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>An abnormal biophysical profile (BPP) predicts which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57154</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>meconium staining</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>A) higher risk for antepartum death within 1 week</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>placental abruption</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>maternal preeclampsia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>a baby that will be small for gestational age (SGA)</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A patient and her husband are extremely anxious about your suggestion that she be given magnesium sulfate for seizure prophylaxis. In assuring her about the safety of the drug, you can emphasize which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57160</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>As a central nervous system (CNS) stimulant it should not deprive her of the awareness of her delivery, unlike barbiturates.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>The drug does not cross the placenta and thus should not affect her fetus/infant.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>The drug is rapidly excreted via the kidney.</p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>The drug has a narrow margin of safety so that we start off with a lower dose in preeclamptics, and administer it by an IV pump.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>It is a mild smooth-muscle constrictor and thus safe for the infusion.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>What malformation should be ( in most cases) detected at 11-14 weeks US examination : </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57189</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>acrania</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Transpotition of the great arteries</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>club foot</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>cleft lip</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Cleft lip</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>In a patient at 22 weeks, you do not succeed in producing an appropriate 4 chambers view. What is  the appropriate management : </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57190</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Do not report any particular finding and ask the pediatrician to check after birth.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Repeat examination two weeks later</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Check ini the third trimester</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Offer an invasive testing</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Refer the patient to a more senior sonographer</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>According to ISUOG guideline, Which of the following item should be routinely assessed in the mid trimester ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57191</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>baby's gender</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>uterine arteries</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>bladder</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>fingers</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ductus venosus</p>

<p> </p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following antiseizure medication, when taken as monotherapy, is associated with the highest of major congenital malformation ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57192</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Dilantin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Phenytoin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>carbamazepine</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Phenobarbital</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Valproic acid</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following can be expected following preconceptional counseling, and its implemantion in women with pregestational diabetes ? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57193</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Decreased peripartum infection rate</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Reduced congenital anomaly rate</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Increased perinatal death rate</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Decreased need for antihypertensive therapy</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>improved ultrasound scanning in second trimester of pregnancy</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Concerning middle cerebral artery Doppler velocimetry, which of the following is true ? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57194</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>It superior to modified biophysycal profile in forcasting pregnancy outcome</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>high resisteance patterns are associaed with bad fetal outcomes</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>it was found tobe inferior to amniocentesis and amniotic fluid spectral analysis for predicting fetal anemia </p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>It is usefull for detection and management of fetal anemia of any causes</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>In those with brain sparing, decreased bllod flow from for reduced cerevrovascular impedance is detected</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. 1. Pemeriksaan penunjang apakah yang paling tepat untuk menegakkan diagnosis kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57238</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Uji Non-Treponemal</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Direct Immuno Florescent</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Uji Serologi HSV</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kultur Spesimen</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Aviditas IgG</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. Apakah etiologi penyebab kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57243</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Clamydia trachomatis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gardnerella vaginosis</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p><b>Treponema pallidum</b></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Neisseria gonorhoe</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Toxoplasma gondii</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. 4. Apakah antibiotik paling tepat untuk pasien ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57246</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Penisilin G</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gentamisin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Meropenem</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Metronidasol</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Seftriakson</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. Apakah komplikasi paling mungkin untuk bayi pada kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57249</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Pneumonitis</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Kematian perinatal</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kelainan jantung</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Ketulian</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hepatosplenomegali</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 29 tahun, G1P0A0, dengan usia kehamilan 12 minggu datang ke Klinik dengan keluhan demam disertai ruam makulopapuler dimulai dari wajah kemudian ke seluruh tubuh dan anggota gerak. Hasil pemeriksaan antibodi IgM Rubella positif. Apakah penatalaksanaan awal pada kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57268</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Imunoterapi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Antibiotik</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Antivirus</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Simtomatik</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Vaksinasi</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 29 tahun, G1P0A0, dengan usia kehamilan 12 minggu datang ke Klinik dengan keluhan demam disertai ruam makulopapuler dimulai dari wajah kemudian ke seluruh tubuh dan anggota gerak. Hasil pemeriksaan antibodi IgM Rubella positif. Komplikasi jangka panjang apakah yang dapat terjadi pada janin dari ibu ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57273</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>DM Tipe 1</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hipertensi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Obesitas</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Penyakit Jantung Koroner</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Aterosklerosis</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Rujukan dari RS B, Umur: 28 th , G1P0A0 gravid 30 minggu His: (-) Pelepasan darah lendir (-) TTV TD: 160/90mmHg N: 155x/menit S: 36,2°C P: 28x/menit Sp02: 73%, tidak dilakukan VT. Hasil primary survey</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57283</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Primary survey, gawat napas e.c. desaturasi, hipertensi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ABC, desaturasi, hipertensi, kemungkinan edema paru</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>ABC, gawat napas e.c desaturasi, takikarida, hipertensi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Primary survey, kegawatan napas, preeklampsia</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Untuk  soal yang sama, tindakan yang paling awal dilakukan</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57291</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Terapi Oksigen dengan NRM 8-10 liter</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Terapi oksigen titrasi dengan kanul sampai 95%</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Resusitasi dengan ventilasi mekanik PEEP</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Terapi oksigen dan pemberian dexametason</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Untuk soal yang sama di atas, dengan umur kehamilan 30 minggu, dan kondisi ibu seperti di atas, pilihan tindakan yang tepat</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57298</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Cek lab: AGD, d-dimer, CRP</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Tergantung respon kondisi ibu setelah resusitasi oksigen, seksio sesar langsung juga menyebabkan peningkatan sitokin pro-inflamasi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Konservatif karena kehamilan belum aterm</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Langsung Cito SC, karena kegawatan ibu, survival bayi 30 minggu cukup baik. Keadaan desaturasi membuat hipoksemia janin</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Melanjutkan skenario soal sebelumnya. Tindakan anestesi yang paling tepat untuk kasus ini bila dilakukan operasi</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57302</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Combine spinal dan epidural</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Spinal anestesi</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>General anestesi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Epidural anestesi</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Terapi profilaksis anti koagulan pada kasus covid diberikan dengan pertimbangan:</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57308</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Semua pasien inpartu mempunyai potensi terjadi hiperkoagulasi. Harus diberikan antikoagulan</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Untuk profilaksis antepartum yg tidak termasuk berat atau kritikal yang akan melahirkan dalam beberapa hari dapat diberikan unfractionated heparin 5000 units subkutan setiap 12 jam.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Low molecular weight heparin 40 mg per hari untuk yang belum melahirkan dalam waktu dekat</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>pemberian antikoagulan pada derajat  ringan, tergantung kadar d-dimer</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following findings are considered diagnostics for overt diabetes in pregnancy?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57313</idnumber><single>false</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[Glucosuria on urine dip]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[Fasting plasma glucose <font face="Symbol">at least or more than </font>120 mg/dl]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[Hemoglobin A1c >6%]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<span lang="EN-US" style="color:black">Random plasma glucose <font face="Symbol">at least or more than </font></span><span lang="EN-US" style="color:black">200 mg/dl</span>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>2. Which of the following statement is true regarding the management of women with gestational diabetes mellitus?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57319</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>The recommended dietary composition includes 20% protein, 50% carbohydrate and 30% fat</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Women with diet-controlled GDM should be monitored with weekly laboratory glucose determinations</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p><span lang="EN-US" style="color:black">Self-blood glucose monitoring regimens should include postprandial determinations</span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Metformin therapy is recommended as adjunctive therapy for women with severe insulin resistance</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN ULANG FETOMATERNA II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>3. Threshold values of International Association of Diabetes and Pregnancy Study Group Consensus Panel for diagnosis of gestational diabetes mellitus</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57349</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>1-hr 75 gr OGTT 153 mg/dl or 8.5 mmol/L</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>A1c 6,8%</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>2-hr 75 gr OGTT 180 mg/dl or 10.0 mmol/L</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p><span lang="EN-US" style="color:black">Fasting plasma glucose 92 mg/dl or 5.1 mmol/L</span></p>]]></text><feedback><text/></feedback></answer></question></quiz>